A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma (Q33265633)

24 July 2017

A novel mutation in the tyrosine kinase domain of ERBB2 in hepatocellular carcinoma (English)

1 reference

Erb-b2 receptor tyrosine kinase 2

24 July 2017

1 reference

inferred from title

hepatocellular carcinoma

1 reference

1

Tanios Bekaii-Saab

1 reference

24 July 2017

Charis Eng

5

0 references

author name string

Nita Williams

series ordinal

2

1 reference

24 July 2017

Christoph Plass

series ordinal

3

1 reference

24 July 2017

Miguel Villalona Calero

series ordinal

4

1 reference

24 July 2017

language of work or name

English

0 references

publication date

6 December 2006

1 reference

24 July 2017

1 reference

24 July 2017

6

1 reference

24 July 2017

278

1 reference

Creative Commons Attribution 2.0 Generic

24 July 2017

start time

1 December 2006

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2407-6-278

0 references

cites work

Phase II study of Erlotinib (OSI-774) in patients with advanced hepatocellular cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Lung cancer: intragenic ERBB2 kinase mutations in tumours

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

EGF receptor gene mutations are common in lung cancers from "never smokers" and are associated with sensitivity of tumors to gefitinib and erlotinib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

The ErbB/HER receptor protein-tyrosine kinases and cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Activating mutations in the epidermal growth factor receptor underlying responsiveness of non-small-cell lung cancer to gefitinib

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Gene amplification and mRNA and protein overexpression of c-erbB-2 (HER-2/neu) in human intrahepatic cholangiocarcinoma as detected by fluorescence in situ hybridization, in situ hybridization, and immunohistochemistry

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Expression and clinical significance of erb-B receptor family in hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Altered PTEN expression as a diagnostic marker for the earliest endometrial precancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Response of some head and neck cancers to epidermal growth factor receptor tyrosine kinase inhibitors may be linked to mutation of ERBB2 rather than EGFR.

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-6-278

Lack of somatic mutations in EGFR tyrosine kinase domain in hepatocellular and nasopharyngeal carcinoma.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-6-278

Investigation of ErbB1 and ErbB2 expression for therapeutic targeting in primary liver tumours

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1712353

Frequent somatic mutations in PTEN and TP53 are mutually exclusive in the stroma of breast carcinomas

31 October 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186%2F1471-2407-6-278

Expression and clinical significance of the erbB family in intrahepatic cholangiocellular carcinoma

21 January 2018

1 reference

12 December 2020

[Quantitative detection of HER-2 oncogene amplification in primary hepatocellular carcinoma using dual FISH technique and its clinical significance]

1 reference

12 December 2020

[Expression of c-erbB-2 protein and EGF receptor in hepatitis B, cirrhosis and hepatocellular carcinoma]

1 reference

12 December 2020

Significance of c-erbB-2 expression in normal and neoplastic epithelium of biliary tract

1 reference

12 December 2020

Rising incidence of hepatocellular carcinoma in the United States

1 reference

12 December 2020

Identifiers

DOI

10.1186/1471-2407-6-278

1 reference

Dimensions Publication ID

24 July 2017

0 references

1 reference

24 July 2017

1 reference